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Skeletal growth is achieved by endochondral ossification
in the growth plate cartilage with orderly columnar arrays
of resting, proliferative, and hypertrophic zones of
chondrocytes. Cyclic GMP-dependent protein kinase II
(cGKII) is a kinase that lies downstream of the C-type
natriuretic peptide (CNP)/GC-B pathway which is essen-
tial for skeletal growth in both humans and rodents. We
found that a naturally occurring mutant rat KMI that lacks
the kinase domain of cGKII exhibits dwarfism due to the
impaired hypertrophic differentiation of growth plate
chondrocytes [1]. cGKII caused attenuation of the tran-
scriptional function of Sox9, an inhibitor of chondrocyte
hypertrophy, through inhibition of nuclear entry. How-
ever, inhibition of the nuclear entry was independent of
the phosphorylation of Sox9 itself, suggesting that other
phosphorylation targets of cGKII are important.
The cGKII-deficient (cGKII-/-) mice also showed dwarfism
with an elongated growth plate due to impairment of
chondrocyte hypertrophy [2]. A screen using a kinase sub-
strate array identified glycogen synthase kinase-3 (GSK-
3) as a principal phosphorylation target of cGKII. Phos-
phorylation of GSK-3 caused its inhibition and this was
associated with enhanced hypertrophic differentiation of
cultured chondrocytes. cGKII-induced chondrocyte
hypertrophy was suppressed by co-transfection with a
phosphorylation-deficient mutant of GSK-3 at Ser9
(GSK-3S9A). Analyses of mice with compound deficien-
cies in both protein kinases (cGKII-/-;GSK-3+/-) demon-
strated that growth retardation and elongated growth
plate caused by cGKII deficiency were partially alleviated
by haploinsufficiency of GSK-3. cGKII and GSK-3 were
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co-localized in prehypertrophic chondrocytes of the
growth plate with -catenin, whose level was decreased in
the cGKII-/- mice. Overexpression of cGKII increased the
accumulation and transactivation function of -catenin in
ATDC5 cells, which were blocked by co-expression of
GSK-3S9A. Figure 1.
Conclusion
Hypertrophic differentiation of growth plate chondro-
cytes during skeletal growth is promoted by Ser9 phos-
phorylation and inactivation of GSK-3, as well as the
Sox9 transcriptional inhibition, by cGKII.
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